These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36539841)

  • 21. Species Distribution and Antifungal Susceptibility Profiles of Isolates from Women with Nonrecurrent and Recurrent Vulvovaginal Candidiasis.
    Rolo J; Faria-Gonçalves P; Barata T; Oliveira AS; Gaspar C; Ferreira SS; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Costa-de-Oliveira S; Palmeira-de-Oliveira A
    Microb Drug Resist; 2021 Aug; 27(8):1087-1095. PubMed ID: 33646045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survey of healthcare providers' testing practices for vulvovaginal candidiasis and treatment outcomes-United States, 2021.
    Benedict K; Moret R; Molinari NAM; Jackson BR
    PLoS One; 2022; 17(12):e0278630. PubMed ID: 36584109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
    Venugopal D; Husain K; Mustafa SA; Sabeen S
    J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulvovaginal candidiasis: a current update.
    Carcio HA; Secor RM
    Nurse Pract Forum; 1992 Sep; 3(3):135-44. PubMed ID: 1472885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
    Li X; Chen S; Lyu X; Tian J
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vulvovaginal candidiasis in Iran: A systematic review and meta-analysis on the epidemiology, clinical manifestations, demographic characteristics, risk factors, etiologic agents and laboratory diagnosis.
    Sasani E; Rafat Z; Ashrafi K; Salimi Y; Zandi M; Soltani S; Hashemi F; Hashemi SJ
    Microb Pathog; 2021 May; 154():104802. PubMed ID: 33741400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
    Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
    Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of adherence to therapy and exploring of barriers and facilitators in HIV positive patients in Tabriz-Iran: a mixed method study protocol.
    Ghanbari A; Khiaban MO; Aslani A; Faraji AR; Mohammadi M; Kazemi AF
    Reprod Health; 2019 Jul; 16(1):108. PubMed ID: 31315629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The statement of Polish Gynecological Society Experts on the etiology and treatment of recurrent vulvovaginal candidiasis].
    Ginekol Pol; 2011 Nov; 82(11):869-73. PubMed ID: 22384623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vulvovaginal candidiasis: a review of the literature.
    Dovnik A; Golle A; Novak D; Arko D; Takač I
    Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(1):5-7. PubMed ID: 25770305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
    Ray A; Ray S; George AT; Swaminathan N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.
    Bond CM; Watson MC;
    Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for recurrent vulvovaginal candidiasis.
    Janković S; Bojović D; Vukadinović D; Daglar E; Janković M; Laudanović D; Lukić V; Misković V; Potpara Z; Projović I; Cokanović V; Petrović N; Folić M; Savić V
    Vojnosanit Pregl; 2010 Oct; 67(10):819-24. PubMed ID: 21061843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parents' approaches to sexuality education of their adolescent boys: a qualitative study in Ahvaz, Iran.
    Rouhparvar Z; Javadnoori M; Shahali S
    Reprod Health; 2022 Mar; 19(1):69. PubMed ID: 35305661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
    Denison HJ; Worswick J; Bond CM; Grimshaw JM; Mayhew A; Gnani Ramadoss S; Robertson C; Schaafsma ME; Watson MC
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD002845. PubMed ID: 32845024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic and recurrent vulvovaginal candidiasis].
    Kubota T
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(4):213-8. PubMed ID: 9795266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The statement of Polish Gynecological Society Experts on the treatment of acute vulvovaginal candidiasis with prolonged releasing 2% butoconazole nitrate vaginal cream--state of art in 2008].
    Expert Board of Polish Gynecological Society
    Ginekol Pol; 2009 Apr; 80(4):303-11. PubMed ID: 19507567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of acute and recurrent vulvovaginal candidiasis (VVC/rVVC)--state of art in 2008. Expert Board of Polish Gynecological Society].
    Kotarski J; Drews K; Maleszka R; Rechberger T; Woroń J; Tomaszewski J;
    Ginekol Pol; 2008 Sep; 79(9):638-52. PubMed ID: 18939517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.